NLE Foundations of Medical-Surgical Nursing — Fluid, Electrolyte and Acid-Base ImbalancesStudy Notes

Total body water comprises approximately 60% of adult body weight. This water exists in two major compartments: the intracellular fluid (ICF) compartment, which contains roughly two-thirds of total body water, and the extracellular fluid (ECF) compartment, which contains approximately one-third. The ECF is further subdivided into two clinically important spaces: the intravascular space (plasma, roughly 25% of ECF) and the interstitial space (tissue fluid, roughly 75% of ECF). Understanding these compartments is essential because different types of fluid and electrolyte losses affect different compartments differently. For example, hemorrhage directly depletes the intravascular space, while diarrhea causes isotonic loss from both plasma and interstitium. Water movement between compartments is governed by osmosis—the movement of water across a semipermeable membrane from an area of lower solute concentration to an area of higher solute concentration. The major solutes creating osmotic gradients are sodium (Na⁺) in the ECF and potassium (K⁺) in the ICF, along with plasma proteins (particularly albumin) in the intravascular space. Because sodium is the major determinant of extracellular osmolality, sodium disorders are fundamentally water distribution problems. Fluid balance is maintained through several regulatory mechanisms working in concert. The thirst mechanism, located in the hypothalamus, triggers fluid intake when osmolality rises or when ECF volume drops. Antidiuretic hormone (ADH), released from the posterior pituitary, increases water reabsorption in the collecting ducts of the nephrons when plasma osmolality is elevated or blood pressure drops. The renin-angiotensin-aldosterone system (RAAS) responds to decreased renal perfusion by activating aldosterone, which promotes sodium and water reabsorption in the distal tubule and collecting duct, thereby expanding ECF volume. Atrial natriuretic peptide (ANP), released by atrial myocytes in response to atrial stretch from volume expansion, antagonizes the RAAS by promoting sodium and water excretion. The kidneys are the primary regulators of both fluid and electrolyte homeostasis, and any significant renal dysfunction directly impacts the body's ability to maintain balance. In Filipino patients with chronic kidney disease (a significant burden in the Philippine health system), these regulatory mechanisms progressively fail, necessitating intensive monitoring and intervention.

Fluid volume deficit (FVD), also called hypovolemia, represents a loss of ECF volume. In most cases, this reflects isotonic loss—loss of both water and electrolytes in proportions similar to their concentrations in plasma. This is the most common type of volume deficit and contrasts with losses that are hypotonic (relatively more water loss) or hypertonic (relatively more electrolyte loss). Common causes of FVD include gastrointestinal losses (vomiting, diarrhea, nasogastric suction), hemorrhage, excessive diuresis (from loop or thiazide diuretics), third-spacing (fluid shifts into the interstitium or body cavities and becomes unavailable to the intravascular space), and inadequate fluid intake. In the Philippine context, acute gastroenteritis (rotavirus, norovirus, bacterial pathogens) is a leading cause of FVD, particularly in children and young adults. Dengue fever and dengue hemorrhagic fever cause FVD through plasma leakage into the interstitial space and potential hemorrhage. Diuretic overuse in elderly patients self-medicating or in resource-limited settings where medications are obtained without proper medical supervision also contributes significantly. The body compensates for FVD through activation of the sympathetic nervous system and RAAS. Catecholamine release increases heart rate and vasoconstriction to maintain blood pressure and perfusion to vital organs. However, as volume depletion progresses, these compensatory mechanisms fail and shock ensues. Clinical manifestations of FVD reflect decreased intravascular volume and tissue perfusion. Early signs include tachycardia (the body's attempt to maintain cardiac output with less circulating volume), orthostatic hypotension (a drop in systolic BP of ≥15 mmHg or increase in heart rate of ≥15 bpm on moving from lying to standing), and decreased skin turgor. Flat or collapsed neck veins indicate reduced venous return. Dry mucous membranes, thirst, decreased urine output (oliguria, defined as <30 mL/hour or <400 mL/day), and elevated urine specific gravity (>1.030) reflect the kidneys' attempt to conserve water. Laboratory findings show hemoconcentration with elevated hematocrit, elevated BUN (urea nitrogen), and elevated serum osmolality. The BUN-to-creatinine ratio is typically elevated (>20:1) because urea is reabsorbed along with water in the proximal tubule, while creatinine is not. Nursing priorities in FVD management focus on restoring circulating volume and preventing progression to hypovolemic shock. Nurses must assess and monitor vital signs frequently, paying special attention to orthostatic changes and trends in heart rate (persistently elevated heart rate despite treatment suggests inadequate volume restoration). Daily weight measurement at the same time of day (preferably early morning after voiding) provides objective data about fluid status—a 1 kg change roughly equals 1 L of fluid. Strict intake and output (I&O) monitoring, including estimation of insensible losses and abnormal routes (vomit, stool, drainage), is essential. Assessment of skin turgor, mucous membrane moisture, and capillary refill provides bedside evidence of tissue perfusion. Level of consciousness changes (confusion, restlessness, decreased alertness) suggest inadequate cerebral perfusion and warrant urgent intervention. Intravenous therapy with isotonic fluids (0.9% NaCl or lactated Ringer's solution) is the cornerstone of treatment, administered at volumes and rates determined by the severity of deficit and the patient's renal and cardiac function. The priority is rapid restoration of the intravascular volume to prevent shock. In hemorrhagic FVD, blood products may be necessary. Once the patient can tolerate oral intake, transition to oral rehydration solutions containing both water and electrolytes (sodium and glucose facilitate water absorption in the small intestine via active transport). Fall precautions are essential because orthostatic hypotension places patients at high risk for syncope and injury. Caregivers should be educated to report signs of ongoing FVD: continued thirst, dark urine, persistent dizziness, or decreased urine output despite treatment.

Fluid volume excess (FVE), also called hypervolemia, represents isotonic expansion of the ECF from sodium and water retention. Unlike FVD, which results from net loss of fluids, FVE results from net retention or excessive intake of both sodium and water in isotonic proportions. Common causes include conditions that reduce effective circulating volume (heart failure, cirrhosis, nephrotic syndrome), conditions that impair water and sodium excretion (renal failure, SIADH—syndrome of inappropriate antidiuretic hormone), and conditions of excessive sodium intake or IV fluid administration. In the Philippine healthcare setting, acute exacerbation of heart failure (often triggered by medication non-adherence in patients not enrolled in PhilPEN programs), advanced cirrhosis from hepatitis B (a significant public health burden in the Philippines), and acute kidney injury in hospitalized patients are frequent causes. Over-infusion of normal saline or other IV fluids in resource-limited settings where nursing staff may be less experienced can iatrogenically cause FVE. In FVE, both the intravascular and interstitial spaces expand, but they do not expand proportionately. The interstitial space is more distensible and accumulates more fluid, resulting in edema. Pulmonary edema is a particularly dangerous complication because it impairs gas exchange and can progress to acute respiratory distress syndrome (ARDS). Clinical manifestations of FVE reflect expanded intravascular volume and pulmonary congestion. A bounding pulse (full and strong pulse with wide pulse pressure) replaces the rapid, weak pulse of hypovolemia. Distended jugular veins (visible even when the patient is upright), elevated blood pressure, and signs of pulmonary congestion (crackles or "rales" on auscultation, dyspnea, orthopnea, and paroxysmal nocturnal dyspnea) indicate pulmonary edema. Peripheral edema (pitting edema in dependent areas such as the lower extremities when standing or sacrum when bedridden) and sacral edema in bedridden patients reflect interstitial fluid accumulation. Weight gain occurs rapidly (1–2 kg over hours to days), and hematocrit and hemoglobin are decreased (hemodilution from increased plasma volume). In severe FVE, patients develop acute pulmonary edema with pink, frothy sputum (a medical emergency). Nursing priorities in FVE management depend on the acuity and severity of pulmonary involvement. If respiratory distress is present, position the patient in semi- to high-Fowler's position (60–90 degrees upright) to facilitate diaphragmatic excursion and reduce pulmonary congestion—this is an immediate priority intervention that does not require a physician's order and can be initiated by the nurse. Restrict sodium and fluids as ordered; typical fluid restrictions are 1–1.5 L/day in moderate to severe FVE. Strict I&O monitoring and daily weight assessment (weigh at the same time each day; a gain of 1–2 kg in one day is significant and should be reported) guide therapy. Diuretics, particularly loop diuretics such as furosemide, are administered to promote sodium and water excretion. Nurses must monitor for diuretic-induced hypokalemia (excessive potassium loss) and other electrolyte disturbances, assessing for muscle weakness, cramping, or cardiac dysrhythmias. Auscultate lung fields regularly (at minimum every 4 hours or more frequently in acute settings) to detect early crackles or worsening pulmonary edema. Oxygen therapy is provided if SpO₂ drops below 95%. If acute pulmonary edema develops (indicated by acute dyspnea, crackles throughout lung fields, pink frothy sputum), this is a medical emergency requiring immediate physician notification, higher-flow oxygen, upright positioning, and likely IV diuretics and possibly vasodilators. Patient and caregiver education focuses on sodium and fluid restriction, daily weight monitoring with instructions to report gains of 1–2 kg, taking diuretics in the morning to avoid nocturia, and recognizing signs of worsening pulmonary edema (increased dyspnea, orthopnea, weight gain) that warrant urgent evaluation.

Sodium (Na⁺) is the major cation of the extracellular fluid and is the chief determinant of serum osmolality (normal plasma osmolality = 2 × Na⁺ + glucose/18 + BUN/2.8). Because osmolality drives water distribution between compartments, sodium disorders are fundamentally water distribution problems. The normal serum sodium range is 135–145 mEq/L. Values below 135 represent hyponatremia; values above 145 represent hypernatremia. **HYPONATREMIA (Na⁺ <135 mEq/L):** Hyponatremia develops when there is relative or absolute water excess compared to sodium. This can occur from three main mechanisms: (1) loss of sodium-rich fluid (vomiting, diarrhea, diuretics, adrenal insufficiency), (2) excessive water intake (SIADH, compulsive water drinking, excessive hypotonic IV fluids), or (3) dilutional hyponatremia in which both sodium and water are lost, but water is retained disproportionately. The severity of hyponatremia is classified by serum sodium level: mild hyponatremia (130–134 mEq/L), moderate hyponatremia (125–129 mEq/L), and severe hyponatremia (<125 mEq/L). Acute hyponatremia (developing over <48 hours) causes more severe symptoms than chronic hyponatremia (developing over >48 hours) because the brain has no time to adapt; in chronic hyponatremia, the brain excretes osmotically active substances (osmolytes) to equalize osmolality and reduce swelling. Manifestations of hyponatremia are largely neurologic and result from cellular swelling (hypotonic solution in ECF pulls water into ICF, including cerebral cells). Symptoms include headache, confusion, restlessness, muscle cramps, nausea, weakness, and in severe cases, seizures, coma, and respiratory arrest from brainstem herniation. Symptoms typically appear when sodium drops below 125 mEq/L or when the drop is very rapid. Management depends on the underlying cause and severity. For hypovolemic hyponatremia (accompanied by signs of FVD), the primary intervention is isotonic saline (0.9% NaCl) to restore circulating volume; as volume is restored, ADH is suppressed and free water is excreted. For euvolemic hyponatremia (in conditions like SIADH or excessive water intake), fluid restriction to 500–1000 mL/day is the primary intervention, allowing endogenous solutes to be excreted while water is restricted. For hypervolemic hyponatremia (in conditions like heart failure or cirrhosis with ascites), both fluid and sodium restriction are implemented along with diuretics. A critical principle in hyponatremia correction is to correct slowly—the serum sodium should be raised by no more than 8–10 mEq/L in the first 24 hours and by no more than 18 mEq/L in 48 hours. Rapid correction risks osmotic demyelination syndrome (ODS, formerly called central pontine myelinolysis), a potentially fatal neurologic condition in which myelin is stripped from neurons in the pons and elsewhere due to sudden osmotic shifts. Hypertonic 3% saline is reserved for symptomatic hyponatremia (seizures, coma) and must be given cautiously with frequent sodium checks (every 2–4 hours initially) and slow infusion rates to raise sodium gradually. Nurses must monitor neurologic status closely and report new or worsening headache, confusion, lethargy, or seizure activity. **HYPERNATREMIA (Na⁺ >145 mEq/L):** Hypernatremia develops when there is water loss in excess of sodium loss (absolute water depletion) or sodium gain in excess of water gain. Common causes include inadequate water intake (elderly patients with diminished thirst, unconscious patients, patients on nasogastric feeding without adequate free water), excessive water loss (diabetes insipidus—inadequate ADH or renal resistance to ADH, hyperventilation, diarrhea), and excessive sodium intake (hypertonic tube feedings, hypertonic saline administration, excessive salt ingestion). Manifestations of hypernatremia reflect cellular dehydration (hypertonic ECF pulls water out of cells, including brain cells). Symptoms include thirst (which may be absent in elderly patients or those with impaired cognition), dry mucous membranes, restlessness, agitation, lethargy, disorientation, and in severe cases, seizures, coma, and intracranial bleeding from ruptured blood vessels. Unlike hyponatremia, which typically presents with neurologic symptoms at high sodium levels, hypernatremia can cause symptoms at lower elevations because the brain shrinks away from the dura, potentially tearing blood vessels. Management focuses on providing free water to correct the hypernatremia slowly. Hypotonic IV fluids (0.45% NaCl or 0.33% NaCl) or, if the patient can tolerate oral intake, free water through oral rehydration or nasogastric tube are used. The correction rate should be slow (no faster than 10–12 mEq/L per 24 hours) to avoid cerebral edema. Rapid correction of hypernatremia by administering too much free water too quickly can cause water to shift into cells (including brain cells), leading to cerebral edema and neurologic deterioration. Treatment of the underlying cause is essential—for example, in diabetes insipidus, ADH replacement (desmopressin) is given; in hypernatremic dehydration from poor intake, education and assistance with drinking are provided. A critical nursing principle applies to both hyponatremia and hypernatremia: never correct sodium disorders rapidly. Monitor serum sodium levels frequently (every 2–4 hours during active correction), assess neurologic status regularly, and report any change in mental status, headache, weakness, or seizure activity. Teach patients and caregivers about adequate fluid intake (especially for those at risk of hypernatremia), the signs of sodium imbalance, and the importance of adhering to sodium restrictions when prescribed.

Potassium (K⁺) is the major cation of the intracellular fluid and is critical to the electrical and contractile properties of cardiac and skeletal muscle and to smooth muscle function. The normal serum potassium range is 3.5–5.0 mEq/L, but clinically significant effects occur even within the "normal" range because serum potassium represents only 2% of total body potassium; the remaining 98% is in the ICF. Both hypokalemia and hyperkalemia are potentially fatal because of their profound effects on cardiac rhythm and conduction. **HYPOKALEMIA (K⁺ <3.5 mEq/L):** Hypokalemia develops when total body potassium is depleted or when potassium shifts into cells (as in alkalosis, where hydrogen ions shift out of cells and potassium shifts in to maintain electroneutrality). Common causes include medications (loop and thiazide diuretics, which increase urinary potassium excretion; corticosteroids; amphotericin B), gastrointestinal losses (vomiting, diarrhea, nasogastric suction), alkalosis (metabolic or respiratory), and renal losses from various disorders. In the Philippine healthcare setting, diuretic overuse in elderly patients, particularly those self-managing hypertension or heart failure without close supervision, is a frequent cause. Chronic diarrhea from poorly treated inflammatory bowel disease or infectious causes also contributes. Manifestations of hypokalemia are primarily neuromuscular and cardiac. Skeletal muscle effects include generalized weakness, leg cramps, fatigue, and in severe cases, rhabdomyolysis and respiratory muscle weakness. Smooth muscle effects include decreased gut motility, resulting in decreased bowel sounds, constipation, and in severe hypokalemia, paralytic ileus (complete cessation of bowel peristalsis). Cardiac manifestations include dysrhythmias, which range from frequent premature ventricular contractions to ventricular fibrillation and asystole. The characteristic ECG changes of hypokalemia include **flattened or inverted T waves, ST segment depression, and prominent U waves** (a small deflection between the T wave and the next P wave, seen best in the precordial leads). These ECG changes indicate increased susceptibility to dysrhythmias and warrant urgent potassium replacement. Management of hypokalemia focuses on identifying and treating the underlying cause (e.g., addressing ongoing diarrhea, adjusting diuretics, correcting alkalosis) and repleting potassium. Oral potassium supplementation is preferred when the patient can tolerate it and the deficit is mild to moderate. Common oral formulations include potassium chloride (KCl) and potassium-containing salt substitutes. For severe hypokalemia or when oral intake is not possible, IV potassium replacement is necessary, but this requires strict adherence to safety protocols. **A cardinal rule in nursing: never administer potassium by intravenous push (bolus).** IV potassium can cause fatal cardiac dysrhythmias (hyperkalemia from rapid elevation) or vein sclerosis. Potassium for IV administration must be diluted in IV fluid (usually to a concentration of 20–40 mEq/L in normal saline or dextrose) and infused slowly. On a general medical/surgical unit, the maximum infusion rate is **10 mEq/hour**; faster rates (up to 20 mEq/hour) are used only in intensive care settings with continuous cardiac monitoring. Before administering IV potassium, the nurse must ensure adequate urine output (at least 30 mL/hour) to verify that the kidneys are functioning and can excrete potassium if serum levels rise too high. Patients should be placed on continuous cardiac monitoring when receiving IV potassium. Patient education includes instruction to consume potassium-rich foods (bananas, oranges, potatoes, tomatoes, spinach, beans) and to take potassium supplements with food (to reduce gastrointestinal irritation). Patients on diuretics should be counseled about signs of hypokalemia (muscle weakness, leg cramps, palpitations) and should not discontinue potassium supplements without medical guidance, as many diuretics cause ongoing potassium wasting. **HYPERKALEMIA (K⁺ >5.0 mEq/L):** Hyperkalemia develops when total body potassium is excessive or when potassium shifts out of cells (as in acidosis, where hydrogen ions shift into cells and potassium shifts out). Common causes include renal failure (the kidneys cannot excrete potassium), potassium-sparing diuretics (spironolactone, amiloride, triamterene), tissue trauma or rhabdomyolysis (intracellular potassium is released when cells break down), acidosis (both metabolic and respiratory), Addison's disease (adrenal insufficiency from which aldosterone is lacking; aldosterone normally promotes potassium excretion), and excessive potassium intake or supplementation. In the Philippine context, chronic kidney disease (a major public health issue) is a leading cause. Patients with both heart failure (treated with ACE inhibitors or angiotensin receptor blockers, which reduce aldosterone) and kidney disease are at particularly high risk. Manifestations of hyperkalemia are primarily cardiac and reflect altered cardiac electrical activity. Symptoms include muscle weakness, paresthesias (tingling sensations), and cardiac dysrhythmias. The characteristic ECG changes evolve with increasing potassium levels and include tall, peaked T waves (narrower at the base than hypokalemia's T waves), widened QRS complex, and prolonged PR interval. As potassium rises further, the P wave flattens and may disappear, the QRS widens further, and the ECG may develop a "sine wave" pattern (combination of QRS and T wave into a single undulating wave). Ultimately, ventricular fibrillation or asystole occurs. Management of hyperkalemia is a medical emergency and involves three types of interventions: (1) stabilize the cardiac membrane, (2) shift potassium into cells, and (3) remove potassium from the body. *Stabilize the cardiac membrane:* IV calcium gluconate (10% solution, typically 10 mL IV over 2–5 minutes) is administered. Calcium does NOT lower serum potassium but protects the myocardium by stabilizing the cell membrane and making dysrhythmias less likely. This is a temporizing measure that must be followed by definitive treatments. In patients on digitalis (digoxin, rarely used in modern practice), calcium is given cautiously because it increases digitalis toxicity; calcium chloride is used instead of calcium gluconate in these rare cases. In facilities where calcium gluconate is unavailable, 10% calcium chloride can be used but should be given through a central line (peripheral IV administration risks extravasation and tissue necrosis). *Shift potassium into cells:* Regular (short-acting) insulin plus dextrose shifts potassium into cells by promoting glycogen synthesis. A typical dose is 10 units of regular insulin IV followed by 25 g of dextrose (e.g., 50 mL of D50W) over 15 minutes. The effect begins in 10–20 minutes and lasts 4–6 hours. Sodium bicarbonate (if the patient is acidotic) shifts potassium into cells by correcting acidosis; a typical dose is 1 ampule (50 mEq) IV over 5–10 minutes. Beta-agonists (e.g., albuterol, terbutaline, isoproterenol) also shift potassium into cells, though they are less commonly used in emergencies than insulin and dextrose. *Remove potassium from the body:* Sodium polystyrene sulfonate (Kayexalate), a potassium-binding resin, is administered orally (15–60 g in 20% sorbitol) or as a retention enema (30 g in 100 mL of 25% dextrose or sorbitol). The resin binds potassium in the gastrointestinal tract and is excreted in stool, effectively removing potassium from the body. Onset is slow (4–24 hours orally; 2–12 hours with enema), so this is not used as a monotherapy in emergencies but is used as a definitive measure after membrane stabilization and cellular shifting have been achieved. **Dialysis** is the most effective method of removing potassium and is indicated in severe hyperkalemia unresponsive to other measures or in renal failure patients who will have ongoing potassium accumulation. The sequence of management in acute hyperkalemia is: (1) continuous cardiac monitoring, (2) IV calcium gluconate to stabilize the myocardium, (3) IV insulin plus dextrose to shift potassium intracellularly, (4) additional agents (sodium bicarbonate if acidotic, beta-agonists) if needed, and (5) sodium polystyrene sulfonate or dialysis to remove potassium. A helpful memory aid for the emergency management is: **"Calcium Stabilizes, Insulin & Glucose Shifts, Kayexalate & Dialysis Remove."** Nurses must be familiar with the IV infusion rates and monitoring requirements for each intervention. Recheck serum potassium 30–60 minutes after initial treatments and frequently thereafter to guide further therapy. Educate patients with chronic hyperkalemia (e.g., those with chronic kidney disease or on ACE inhibitors) about avoiding potassium-rich foods, avoiding potassium supplements, adhering to renal diet restrictions, and reporting muscle weakness or palpitations.

Calcium (Ca²⁺) and magnesium (Mg²⁺) are cations critical to neuromuscular and cardiac function. Normal serum calcium (total) is 8.5–10.5 mg/dL; normal serum magnesium is 1.5–2.5 mEq/L. Roughly 40–50% of serum calcium is bound to plasma proteins (chiefly albumin) and is not physiologically active; the remaining 50–60% is ionized (free) and physiologically active. When interpreting serum calcium in patients with hypoalbuminemia, the total calcium should be "corrected" using the formula: **Corrected Ca²⁺ = Total Ca²⁺ + 0.8 × (4 – serum albumin in g/dL)**. **HYPOCALCEMIA (Total Ca²⁺ <8.5 mg/dL):** Hypocalcemia develops when there is calcium loss, decreased calcium intake or absorption, or decreased activation of vitamin D. Common causes include hypoparathyroidism (from thyroidectomy, parathyroidectomy, or idiopathic autoimmune destruction), vitamin D deficiency (from inadequate sun exposure, poor dietary intake, or malabsorption), pancreatitis (elevated phosphate from tissue destruction binds calcium), chronic kidney disease (kidneys cannot activate vitamin D and excrete phosphate), and post-thyroidectomy hypoparathyroidism. In the Philippines, vitamin D deficiency is more prevalent in northern regions with less sunshine and in populations with darker skin pigmentation, who require more sun exposure to synthesize adequate vitamin D. Manifestations of hypocalcemia result from increased neuromuscular irritability. Symptoms include paresthesias (tingling around the mouth, in the fingertips and toes), muscle cramps, tetany (involuntary muscle contractions), and in severe cases, laryngospasm (spasm of the laryngeal muscles that can obstruct the airway) and seizures. Two clinical signs are pathognomonic for hypocalcemia: **Chvostek's sign** (facial twitch elicited by tapping on the facial nerve just anterior to the ear) and **Trousseau's sign** (carpal spasm elicited by inflating a blood pressure cuff above systolic pressure for 3 minutes to cause arterial occlusion). Both signs reflect neuromuscular irritability from hypocalcemia. Severely hypocalcemic patients may also have cardiac dysrhythmias, particularly QT prolongation on the ECG. Management of hypocalcemia depends on severity and acuity. Symptomatic hypocalcemia or severe hypocalcemia (Ca²⁺ <7 mg/dL) requires IV calcium replacement. Calcium gluconate is preferred over calcium chloride for peripheral IV administration (calcium chloride is sclerotic to veins). A typical dose is 10–20 mL of 10% calcium gluconate solution diluted in 50–100 mL of normal saline or dextrose, infused slowly (over 10–20 minutes) while the patient is on continuous cardiac monitoring (hypercalcemia or rapid infusion can cause dysrhythmias). The IV line should be checked frequently for infiltration (calcium precipitates in soft tissue, causing necrosis). Serum calcium should be rechecked 4–6 hours after infusion. For asymptomatic mild hypocalcemia, oral calcium supplements (calcium carbonate, calcium citrate) with vitamin D supplementation may suffice. Treatment of the underlying cause is essential—vitamin D supplementation for vitamin D deficiency, treatment of renal failure and phosphate binders for chronic kidney disease, or monitoring for spontaneous recovery in post-thyroidectomy cases (parathyroid function may recover over weeks). Seizure precautions should be instituted for severely hypocalcemic patients, and the nurse should keep IV calcium gluconate readily available at the bedside in case symptoms worsen or seizures occur. **HYPERCALCEMIA (Total Ca²⁺ >10.5 mg/dL):** Hypercalcemia develops when there is excessive calcium intake or absorption, increased bone resorption, or decreased urinary calcium excretion. The two most common causes are primary hyperparathyroidism and malignancy. Other causes include excessive vitamin D intake (from supplements or foods), excessive vitamin A intake, hyperthyroidism, prolonged immobilization (bone resorption from disuse), and thiazide diuretics (which decrease urinary calcium excretion). In the Philippines, malignancy-related hypercalcemia is common in patients with advanced lung cancer, breast cancer, and multiple myeloma. Manifestations of hypercalcemia result from decreased neuromuscular activity and CNS effects. The classic description is "stones, bones, groans, and psychiatric overtones." Stones refer to kidney stones (from hypercalciuria). Bones refer to bone disease and osteoporosis. Groans refer to gastrointestinal symptoms: nausea, vomiting, constipation, and decreased bowel motility. Psychiatric overtones refer to altered mental status: confusion, depression, anxiety, irritability, lethargy, or psychosis (in severe cases). Neuromuscular symptoms include generalized weakness, decreased muscle tone, and decreased deep tendon reflexes (hypo-reflexia). Cardiac manifestations include hypertension, shortened QT interval on ECG, and potential for dysrhythmias. Severe hypercalcemia (>13 mg/dL) can cause nephrogenic diabetes insipidus (the kidney becomes unresponsive to ADH, resulting in polyuria and further dehydration) and mental status changes that may progress to coma. Management of hypercalcemia begins with IV isotonic saline (0.9% NaCl) to expand intravascular volume and promote urinary calcium excretion. A typical regimen is 200–500 mL/hour of IV 0.9% NaCl, with fluid rates adjusted based on urine output (goal is a urine output of 100–150 mL/hour). Loop diuretics (furosemide) were historically used but are now used less frequently because they cause volume depletion and actually worsen hypercalcemia; they are used only if the patient develops fluid overload during saline administration. More specific treatments include bisphosphonates (e.g., pamidronate, zoledronic acid), which inhibit osteoclast-mediated bone resorption and take 3–7 days to lower calcium but provide sustained effect. Calcitonin inhibits osteoclast activity and increases urinary calcium excretion; onset is rapid (within hours) but duration is brief (24–48 hours), so calcitonin is typically used as a bridge while waiting for bisphosphonates to take effect. Corticosteroids are useful in hypercalcemia from granulomatous diseases (sarcoidosis, tuberculosis) and malignancy-related hypercalcemia. Treatment of the underlying cause is essential—parathyroidectomy for hyperparathyroidism, chemotherapy or other cancer treatment for malignancy-related hypercalcemia, discontinuation of excessive vitamin supplementation. Nursing management of hypercalcemia includes promoting mobility (immobilization worsens bone resorption and hypercalcemia), maintaining adequate hydration, administering IV fluids and diuretics as ordered, monitoring urine output, assessing mental status regularly (confusion may indicate worsening hypercalcemia), monitoring for kidney stones (frank hematuria, flank pain), and educating patients about avoiding high-calcium foods and supplements if appropriate, increasing fluid intake, and maintaining mobility. **HYPOMAGNESEMIA (Mg²⁺ <1.5 mEq/L):** Hypomagnesemia develops when there is magnesium loss or decreased intake. Common causes include gastrointestinal losses (diarrhea, small bowel or pancreatic fistulas, malabsorption), renal losses (loop and thiazide diuretics, aminoglycosides, amphotericin B, PPIs prolonging use), poor dietary intake (malnutrition, alcoholism), and nasogastric suction. In the Philippine context, alcoholism and poor nutrition in certain populations contribute significantly. Notably, hypomagnesemia frequently coexists with hypokalemia (because many diuretics cause both) and hypocalcemia (because hypomagnesemia impairs PTH secretion and PTH action). Manifestations of hypomagnesemia largely mirror those of hypocalcemia—tremor, tetany, paresthesias, muscle cramps, positive Chvostek's and Trousseau's signs, and in severe cases, seizures. Additionally, hypomagnesemia predisposes to cardiac dysrhythmias, including atrial fibrillation and ventricular dysrhythmias such as torsades de pointes (a particularly dangerous ventricular arrhythmia characterized by a "twisting of the points"). A key clinical pearl is that hypokalemia cannot be effectively corrected if hypomagnesemia coexists—magnesium must be repleted first (or simultaneously) for potassium repletion to be successful. Management of hypomagnesemia includes addressing the underlying cause (treating diarrhea, stopping causative medications if possible, improving nutrition) and magnesium supplementation. Oral magnesium supplements (magnesium oxide, magnesium citrate) are used for mild deficits but often cause diarrhea. For significant hypomagnesemia or when oral intake is not possible, IV magnesium sulfate is given. A typical dose is 1–2 g (8–16 mEq) of magnesium sulfate in 50–100 mL of normal saline or dextrose, infused over 5–60 minutes depending on urgency. Faster infusion rates (e.g., over 5 minutes in urgent situations) may cause flushing, sweating, and a sensation of warmth. Serum magnesium should be rechecked 4–6 hours after infusion. During magnesium repletion, deep tendon reflexes should be monitored—hypermagnesemia (a potential complication of repletion, especially if renal function is impaired) causes loss of deep tendon reflexes, so reflexes are assessed at baseline, during repletion, and regularly thereafter. **HYPERMAGNESEMIA (Mg²⁺ >2.5 mEq/L):** Hypermagnesemia is rare and usually occurs in the setting of renal failure (the kidneys cannot excrete magnesium) or excessive magnesium intake (from antacids containing magnesium, laxatives with magnesium, or obstetric magnesium sulfate therapy for pre-eclampsia/eclampsia in patients with renal impairment). In the Philippines, over-the-counter magnesium-containing antacids and laxatives may be overused, particularly in rural areas with limited access to healthcare education. Manifestations of hypermagnesemia result from CNS and neuromuscular depression. Early signs include flushing, sweating, and a sensation of warmth. As magnesium rises, signs include nausea, vomiting, lethargy, drowsiness, and weak deep tendon reflexes. A key finding in hypermagnesemia is **loss of deep tendon reflexes**—this is the clinical hallmark that distinguishes it from other disorders. More severe hypermagnesemia causes muscle weakness, respiratory depression (if severe), hypotension, bradycardia, and potentially cardiac conduction blocks and asystole. Management of hypermagnesemia focuses on stopping exogenous magnesium sources (discontinuing antacids, laxatives, or IV magnesium sulfate). For symptomatic hypermagnesemia, **IV calcium gluconate** is the antidote—it antagonizes the effects of magnesium on the neuromuscular and cardiovascular systems. A typical dose is 10 mL of 10% calcium gluconate IV over 2–5 minutes. This provides immediate symptom relief but does not lower serum magnesium; therefore, removal of magnesium from the body is also necessary. Diuretics (loop diuretics with saline infusion) can be used if renal function permits. Dialysis is the most effective method of magnesium removal and is indicated in severe hypermagnesemia, particularly in the setting of renal failure. Nursing management of both calcium and magnesium imbalances requires careful monitoring of clinical signs, frequent laboratory checks, assessment of deep tendon reflexes (particularly in magnesium disorders), and patient education about dietary sources and supplements.

The body maintains blood pH in a narrow range (7.35–7.45) through the buffer systems, the respiratory system, and the renal system. The normal values are: - **pH**: 7.35–7.45 (below 7.35 = acidemia; above 7.45 = alkalemia) - **PaCO₂** (arterial carbon dioxide tension): 35–45 mmHg (respiratory component of pH regulation) - **HCO₃⁻** (serum bicarbonate): 22–26 mEq/L (metabolic component of pH regulation) - **PaO₂** (arterial oxygen tension): 80–100 mmHg (assesses oxygenation adequacy) - **SaO₂** (arterial oxygen saturation): 95–100% (assesses oxygenation adequacy) The Henderson-Hasselbalch equation, while not used for calculation in clinical practice, illustrates the relationship: **pH = pKa + log([HCO₃⁻]/[H₂CO₃])**. In simplified form, **pH depends on the ratio of HCO₃⁻ to PaCO₂**. When this ratio changes, pH changes. **A stepwise method for ABG interpretation:** **Step 1: Assess the pH.** Is it normal (7.35–7.45), low (<7.35 = acidosis), or high (>7.45 = alkalosis)? This tells you whether the primary disorder is acidosis or alkalosis. **Step 2: Assess the PaCO₂.** Is it normal (35–45), low (<35), or high (>45)? Remember that CO₂ is an acid (CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻). Low PaCO₂ means less acid (alkalinizing effect); high PaCO₂ means more acid (acidifying effect). **Step 3: Assess the HCO₃⁻.** Is it normal (22–26), low (<22), or high (>26)? HCO₃⁻ is a base. Low HCO₃⁻ means less base (acidifying effect); high HCO₃⁻ means more base (alkalinizing effect). **Step 4: Determine if PaCO₂ and HCO₃⁻ are moving in the expected direction for the primary disorder, or in the opposite direction (suggesting compensation).** A helpful memory aid is **ROME**: **R**espiratory **O**pposite (in respiratory disorders, pH and PaCO₂ move in opposite directions), **M**etabolic **E**qual (in metabolic disorders, pH and HCO₃⁻ move in the same direction). **THE FOUR PRIMARY ACID-BASE DISORDERS:** **1. Respiratory Acidosis (pH low, PaCO₂ high):** Caused by hypoventilation—the lungs are not effectively eliminating CO₂. Common causes include COPD (emphysema, chronic bronchitis), acute respiratory depression (from opioid overdose, sedatives, anesthesia), pneumonia, pulmonary edema, chest wall injury (rib fractures, flail chest), and obesity hypoventilation syndrome. The kidneys compensate by reabsorbing more HCO₃⁻, raising HCO₃⁻. In acute respiratory acidosis, there is little time for renal compensation, so HCO₃⁻ may still be normal or only mildly elevated. In chronic respiratory acidosis, the kidneys have had time to compensate robustly, so HCO₃⁻ is notably elevated. Example: A 68-year-old male with COPD exacerbation presents short of breath. ABG: pH 7.28, PaCO₂ 68, HCO₃⁻ 30. **Analysis:** pH is low (acidemia). PaCO₂ is high (hypoventilation—respiratory problem). HCO₃⁻ is high, representing renal compensation (kidneys reabsorbing HCO₃⁻ to raise pH). **Diagnosis:** respiratory acidosis with partial metabolic compensation. **Nursing priority:** improve ventilation (position upright, provide oxygen, consider noninvasive ventilation such as CPAP if not improving, prepare for possible intubation if worsening). **2. Respiratory Alkalosis (pH high, PaCO₂ low):** Caused by hyperventilation—the lungs are eliminating CO₂ faster than it is produced. Common causes include anxiety, pain, fever, early salicylate toxicity (aspirin overdose), hypoxemia (driving respiratory drive), and mechanical overventilation in intubated patients. The kidneys compensate by excreting more HCO₃⁻, lowering HCO₃⁻. As with respiratory acidosis, acute respiratory alkalosis has minimal renal compensation, while chronic alkalosis shows more compensation. Example: A 35-year-old female with anxiety disorder hyperventilates during a panic attack. ABG: pH 7.52, PaCO₂ 28, HCO₃⁻ 22. **Analysis:** pH is high (alkalemia). PaCO₂ is low (hyperventilation—respiratory problem). HCO₃⁻ is normal to low, representing minimal renal compensation. **Diagnosis:** respiratory alkalosis. **Nursing intervention:** calm the patient, have her breathe into a paper bag to rebreathe CO₂ (raising PaCO₂), teach slow, deep breathing, address the underlying anxiety. **3. Metabolic Acidosis (pH low, HCO₃⁻ low):** Caused by loss of HCO₃⁻ or gain of acid (fixed acids or organic acids). Common causes include: - **Diarrhea** (loss of HCO₃⁻ in stool) - **Renal failure** (kidneys cannot excrete acid and cannot reabsorb HCO₃⁻) - **Diabetic ketoacidosis (DKA)** (production of ketoacids from lipolysis) - **Lactic acidosis** (from tissue hypoxia/hypoperfusion in shock, sepsis, or from metformin overuse in patients with renal failure) - **Salicylate toxicity** (aspirin overdose) The respiratory system compensates by hyperventilating to eliminate CO₂, lowering PaCO₂. This is called **Kussmaul respiration** (deep, rapid breathing)—a pathognomonic sign of metabolic acidosis, especially diabetic ketoacidosis. Example: A 24-year-old male with type 1 diabetes presents with polyuria, polydipsia, and malaise. He has not checked his blood glucose or taken insulin for 2 days. ABG: pH 7.15, PaCO₂ 24, HCO₃⁻ 8. Blood glucose 520 mg/dL, serum ketones positive, anion gap 18. **Analysis:** pH is low (acidemia). HCO₃⁻ is very low (loss of HCO₃⁻ from ketoacid production). PaCO₂ is low (respiratory compensation via hyperventilation—Kussmaul respiration). **Diagnosis:** metabolic acidosis (diabetic ketoacidosis) with appropriate respiratory compensation. **Nursing priorities:** IV fluids (0.9% NaCl to restore volume), regular insulin infusion, frequent glucose and electrolyte checks, monitor for complications (hypoglycemia from insulin, hyperkalemia from acidosis shift, hypokalemia from urinary loss and insulin therapy). **4. Metabolic Alkalosis (pH high, HCO₃⁻ high):** Caused by loss of acid or gain of HCO₃⁻. Common causes include: - **Vomiting** (loss of hydrochloric acid from the stomach) - **Prolonged nasogastric suction** (removal of gastric acid) - **Excessive antacid use** (gain of HCO₃⁻) - **Loop or thiazide diuretics** (loss of acid and potassium; hypokalemia perpetuates alkalosis because the kidneys reabsorb HCO₃⁻ to maintain electroneutrality) - **Hyperaldosteronism** (from Conn's syndrome or secondary hyperaldosteronism) - **Corticosteroid overuse** The respiratory system compensates by hypoventilating (reducing respiratory rate, taking shallower breaths) to retain CO₂ and raise PaCO₂. However, respiratory compensation is limited because hypoventilation causes hypoxemia, which drives increased ventilation. Therefore, metabolic alkalosis is often **not well compensated** and can be difficult to correct without treating the underlying cause and addressing associated electrolyte abnormalities (particularly hypokalemia and chloride depletion). Example: A 72-year-old male with a nasogastric tube for bowel obstruction has had continuous drainage for 5 days. He reports nausea and fatigue. ABG: pH 7.52, PaCO₂ 48, HCO₃⁻ 38. Electrolytes: K⁺ 2.8, Cl⁻ 88, Na⁺ 132. **Analysis:** pH is high (alkalemia). HCO₃⁻ is very high (loss of acid from NG suction). PaCO₂ is high (respiratory compensation via hypoventilation, though limited). **Diagnosis:** metabolic alkalosis with respiratory compensation, complicated by hypokalemia and hypochloremia. **Nursing interventions:** (1) Replace fluid losses with IV fluids containing chloride (normal saline or lactated Ringer's, not just dextrose, which does not contain chloride). (2) Potassium replacement as ordered. (3) Discontinue NG suction once bowel obstruction resolves. (4) Monitor electrolytes and ABG frequently. Treatment of metabolic alkalosis typically requires both fluid/electrolyte replacement and treatment of the underlying cause.

The tonicity of an IV fluid—its osmolality relative to plasma—determines how water distributes between the intravascular and interstitial spaces. Understanding tonicity is critical to selecting the appropriate fluid for a given clinical scenario and avoiding serious complications such as cerebral edema or pulmonary edema. **Osmolality** is the concentration of osmotically active solutes per kilogram of solvent and is expressed in milliosmoles per kilogram (mOsm/kg). Normal plasma osmolality is approximately 280–295 mOsm/kg. Fluids are classified as isotonic, hypotonic, or hypertonic based on their osmolality relative to plasma. **ISOTONIC FLUIDS (Osmolality ≈ 280–310 mOsm/kg):** Isotonic fluids have osmolality approximately equal to plasma. When infused, they do not create an osmotic gradient across the cell membrane, so water does not shift between compartments. These fluids expand the intravascular volume (plasma volume) without causing cellular swelling or shrinkage. Common isotonic fluids include: - **0.9% Sodium Chloride (Normal Saline, NS)**: osmolality ≈ 308 mOsm/kg. Contains 154 mEq/L sodium and 154 mEq/L chloride. Note that NS is slightly hypertonic (308 > 295) but is clinically classified as isotonic. It is the most commonly used fluid in hospitals worldwide. - **Lactated Ringer's Solution (LR)**: osmolality ≈ 273 mOsm/kg. Contains 130 mEq/L sodium, 109 mEq/L chloride, 28 mEq/L potassium, 4 mEq/L magnesium, 3 mEq/L calcium, and 28 mEq/L lactate. The lactate is converted to bicarbonate in the liver, providing a mild alkalinizing effect. LR is physiologically closer to plasma composition than NS. - **D5W (5% Dextrose in Water)**: osmolality in the bag ≈ 252 mOsm/kg (hypertonic in the bag). However, once the dextrose is metabolized (which occurs rapidly), D5W effectively becomes 5% free water. Although it is not truly isotonic, it is clinically used in some hypovolemic situations. Use cautiously in patients at risk for increased intracranial pressure. **Clinical uses of isotonic fluids:** - Fluid volume deficit (hypovolemia) and hemorrhage: isotonic fluids rapidly restore intravascular volume and are the treatment of choice for hypovolemic shock. - Initial resuscitation in trauma and sepsis. - Most IV medication administration (as the diluent or carrier). **HYPOTONIC FLUIDS (Osmolality <280 mOsm/kg):** Hypotonic fluids have osmolality lower than plasma. When infused, they create an osmotic gradient that draws water out of the ECF (both intravascular and interstitial) into the ICF. This means hypotonic fluids expand both the ECF and ICF, but the ICF expansion is relatively greater. Common hypotonic fluids include: - **0.45% Sodium Chloride (Half-normal Saline, 0.45% NS)**: osmolality ≈ 154 mOsm/kg. - **0.33% Sodium Chloride (One-third normal Saline, 0.33% NS)**: osmolality ≈ 103 mOsm/kg. - **D5W in small volumes** (once dextrose is metabolized, this becomes hypotonic). **Clinical uses of hypotonic fluids:** - **Cellular dehydration and hypernatremia**: by providing free water that enters cells, hypotonic fluids correct cellular dehydration. - Maintenance fluid in patients without ongoing significant losses. - **CRITICAL CAUTIONS with hypotonic fluids:** - **Avoid in patients at risk for increased intracranial pressure (ICP)**: Examples include patients with traumatic brain injury, stroke, neuro surgery, or encephalitis. Hypotonic fluids cause water to shift into brain cells, increasing cerebral edema and worsening increased ICP. - **Avoid in hypovolemia**: Because hypotonic fluids distribute water throughout all compartments (ICF and ECF), less fluid remains in the intravascular space compared to isotonic fluids. In a hypovolemic patient, this can worsen hypotension and shock. - **Avoid in patients with liver disease or SIADH**: conditions in which free water excretion is impaired. **HYPERTONIC FLUIDS (Osmolality >310 mOsm/kg):** Hypertonic fluids have osmolality higher than plasma. When infused, they create an osmotic gradient that pulls water out of the ICF (and interstitium) into the intravascular space, expanding plasma volume at the expense of ICF volume. Common hypertonic fluids include: - **3% Sodium Chloride (3% NaCl, Hypertonic Saline)**: osmolality ≈ 1026 mOsm/kg. Contains 513 mEq/L sodium and 513 mEq/L chloride. Administered slowly through a central line (peripheral administration can sclerose veins). - **D10W (10% Dextrose in Water)**: osmolality ≈ 505 mOsm/kg. A hypertonic dextrose solution. - **D5 in 0.9% NaCl or D5 in Lactated Ringer's**: hypertonic formulations used for specific situations. **Clinical uses of hypertonic fluids:** - **Severe symptomatic hyponatremia** (with seizures or coma): 3% NaCl is administered cautiously to raise sodium gradually (by 8–10 mEq/L in 24 hours) without causing osmotic demyelination syndrome. Frequent sodium checks are essential. - **Cerebral edema**: Hypertonic saline (3% NaCl) is used to pull fluid out of brain cells, reducing intracranial pressure. It is often used in conjunction with mannitol (an osmotic diuretic). - **Severe hyperglycemia with cerebral edema**: in cases where hyperosmolarity is being corrected too rapidly. **CRITICAL CAUTIONS with hypertonic fluids:** - **Administer slowly** to avoid rapid osmotic shifts that can cause vascular and cellular complications. - **Central line preferred** for 3% NaCl (peripheral administration risks sclerosis and infiltration injury). - **Frequent electrolyte checks** are essential; serum sodium should be checked every 2–4 hours initially when using hypertonic solutions. - **Risk of fluid overload and pulmonary edema**: hypertonic fluids pull fluid into the intravascular space, potentially overwhelming cardiac output. - **Renal dysfunction**: hypertonic solutions require functioning kidneys to excrete the excess electrolytes; avoid or use cautiously in renal failure. **SPECIAL CONSIDERATIONS:** **Blood products:** Packed red blood cells (PRBCs), fresh frozen plasma (FFP), and platelets are not isotonic fluids but are used in acute hemorrhage or specific clotting disorders. PRBCs are given to restore oxygen-carrying capacity; FFP is given for coagulopathy. These are typically given concurrently with isotonic crystalloid fluids (normal saline or lactated Ringer's). **Colloid fluids:** Albumin, dextran, and hydroxyethyl starch (HES) are large-molecule solutions that stay in the intravascular space longer than crystalloids. They are expensive and, based on recent evidence (particularly the SAFE trial), are not superior to crystalloid fluids for most situations. Use is limited to specific scenarios, and in many Philippine hospitals, they are reserved for those who can afford them due to cost. **Fluid balance calculation:** When selecting IV fluids, calculate the total daily requirement, ongoing losses, and deficit. A typical adult requires 30–35 mL/kg/day for maintenance. Additional fluids are given to replace ongoing losses (diarrhea, vomiting, NG drainage) or to correct deficits. Monitoring of I&O, daily weight, vital signs, and clinical assessment guides fluid administration rates. **Nursing assessment and monitoring:** Regularly assess the IV site for signs of infiltration or phlebitis. Monitor the patient's response to IV fluids: vital signs, urine output, neck vein distension, lung sounds (for signs of pulmonary edema), peripheral edema, and mental status. Adjust IV rates based on clinical response and laboratory values. In resource-limited settings (common in provincial Philippine hospitals), careful manual recording of I&O and frequent bedside assessment may be the primary monitoring tools, making clinical nursing judgment essential. When changing or stopping IV fluids, always verify the new fluid order, check the IV site, and monitor the patient closely for changes in vital signs or clinical status. In cases of fluid shifts or electrolyte changes, these can occur relatively rapidly (within minutes to hours), particularly in elderly patients or those with renal or cardiac disease.

Untreated or inadequately managed fluid, electrolyte, and acid-base imbalances progress rapidly to life-threatening complications. As a Filipino nurse regulated under RA 9173 (Philippine Nursing Practice Law) and practicing within the Philippine healthcare delivery system, you must recognize these complications and take prompt nursing action. **ACUTE COMPLICATIONS OF IMBALANCES:** **Hypovolemic Shock:** Severe FVD progresses to shock (inadequate tissue perfusion). Signs include decreased level of consciousness, rapid weak pulse, hypotension, cold clammy skin, and decreased urine output (<20 mL/hr). This is a medical emergency requiring immediate IV fluid resuscitation and physician notification. **Pulmonary Edema:** Severe FVE or rapid IV fluid administration can precipitate pulmonary edema (fluid in the lungs impairing gas exchange). Signs include acute dyspnea, orthopnea, crackles throughout lung fields, and pink frothy sputum. This is a medical emergency requiring immediate positioning (upright), oxygen, and usually IV diuretics and/or vasodilators. **Cardiac Dysrhythmias:** Both hypokalemia (tall U waves, flattened T waves) and hyperkalemia (peaked T waves, widened QRS) predispose to life-threatening arrhythmias such as ventricular fibrillation or asystole. Patients with significant potassium imbalances must be on cardiac monitoring. **Seizures:** Severe hyponatremia, hypocalcemia, hypomagnesemia, and hypoglycemia (which can accompany hypotonic fluid administration) can cause seizures. Seizure precautions include padded side rails, suction readily available, and positioning to prevent aspiration. **Cerebral Edema:** Rapid correction of hypernatremia or too-rapid administration of hypotonic fluids can cause cerebral edema (swelling of the brain), manifesting as worsening headache, confusion, decreased level of consciousness, and potential brainstem herniation. This is a medical emergency. **Osmotic Demyelination Syndrome (ODS):** Rapid correction of chronic hyponatremia causes osmotic shifts that strip myelin from neurons, particularly in the pons. Symptoms appear days after correction and include weakness, dysarthria, behavioral changes, and potentially coma and death. **Prevention is key: correct hyponatremia slowly.** **Acute Kidney Injury (AKI):** Severe hyperkalemia, hypercalcemia, or dehydration can precipitate AKI. Monitor for rising creatinine, decreasing urine output, and electrolyte abnormalities. **PATIENT AND CAREGIVER EDUCATION:** Patient education is a cornerstone of nursing practice (NCM Level 3 and 4 focus on patient education and health promotion). For patients at risk of fluid and electrolyte imbalances, teach and reinforce: **For patients at risk of FVD (e.g., elderly, those with diarrhea, those taking diuretics):** - Signs of dehydration: increased thirst, dark urine, dizziness, dry mouth, weight loss. Advise to report these promptly. - Adequate fluid intake: encourage drinking water and other fluids throughout the day (aim for 8–10 glasses daily, adjusted for individual needs and medical conditions). - Avoid excessive sweating and heat exposure; use cooling measures in hot weather. - For those with gastroenteritis, discuss oral rehydration using solutions containing sodium and glucose (WHO/UNICEF recommended solutions, or commercial equivalents), which are more effective than water alone. - If on diuretics, understand why the medication is necessary, take it as prescribed (often in the morning), and report persistent dizziness or weakness. **For patients at risk of FVE (e.g., heart failure, renal disease, cirrhosis):** - Sodium restriction: teach about high-sodium foods (processed foods, canned goods, salty snacks) and encourage use of herbs and spices for flavoring instead of salt. In the Philippine context, discuss traditional cooking practices that use salt (e.g., salted fish, alamang, bagoong) and suggest lower-salt alternatives or reduced portions. - Fluid restriction: if prescribed (typically 1–1.5 L/day in moderate to severe FVE), teach how to measure fluids (include all beverages and foods with high fluid content such as soups, ice cream). Provide written instructions and consider involving family members in meal planning. - Daily weight monitoring: weigh at the same time each morning after voiding, using the same scale. A gain of 1–2 kg in a day or 2–3 kg in a week is significant and should be reported immediately. Discuss with patients the relationship between weight gain and fluid accumulation. - Diuretic use: take diuretics in the morning to avoid nocturia. Take with food if GI upset occurs. Report muscle weakness (suggesting hypokalemia), dizziness, or persistent cough (suggesting pulmonary edema). - Medication adherence: emphasize that heart failure, hypertension, and renal disease medications must be taken consistently; missing doses can lead to decompensation and hospital readmission. **For patients with electrolyte imbalances:** *Hypokalemia/hypomagnesemia risk:* - Potassium-rich foods: bananas, oranges, potatoes, sweet potatoes, tomatoes, beans, spinach, avocado. In the Philippine context, discuss local fruits and vegetables rich in potassium (e.g., saba banana, native vegetables like pechay and alugbati). - Take potassium supplements with food to reduce GI upset. - Report muscle weakness, leg cramps, palpitations, or constipation. - For patients on diuretics, understand that some diuretics cause potassium loss; discuss whether a potassium-sparing diuretic or potassium supplementation is appropriate. *Hyperkalemia risk:* - Avoid potassium supplements and salt substitutes (which often contain potassium). - Limit potassium-rich foods (especially important in chronic kidney disease). - Adhere to renal diet if prescribed. - Report muscle weakness or palpitations. - For patients on ACE inhibitors or ARBs (which reduce aldosterone and promote potassium retention), understand that these are important cardiac protective medications; discuss with the physician if concerns about hyperkalemia arise. *Hyponatremia/hypernatremia risk:* - Adequate fluid intake for hypernatremia; restriction for hyponatremia. - Signs of imbalance: confusion, headache, weakness, seizures (these require urgent evaluation). **INTEGRATION WITH PHILIPPINE HEALTHCARE DELIVERY AND RA 9173:** Under RA 9173, Filipino nurses are authorized to diagnose and intervene for nursing diagnoses (not medical diagnoses) across the spectrum of health (promotion, prevention, curative, rehabilitative). Within the context of fluid, electrolyte, and acid-base management, key nursing diagnoses related to imbalances include: - **Deficient Fluid Volume** (related to inadequate intake, excessive losses) - **Excess Fluid Volume** (related to sodium/water retention, impaired excretion) - **Imbalanced Nutrition: Less Than Body Requirements** (related to poor intake, malabsorption) - **Risk for Electrolyte Imbalance** (related to medications, disease processes) - **Acute Confusion** (related to electrolyte imbalances, pH changes) - **Risk for Injury** (related to muscle weakness from electrolyte imbalances) Nursing interventions include assessment, monitoring, patient education, medication administration (under physician's order), IV fluid administration, and collaboration with physicians and other healthcare team members. In the Philippine healthcare context, many nurses work in understaffed settings, particularly in rural areas. This demands **prioritization using Maslow's hierarchy**: airway and breathing (respiratory alkalosis/acidosis, pulmonary edema) take precedence over fluid volume or electrolyte concerns unless the latter are immediately life-threatening (e.g., hyperkalemia with peaked T waves on ECG). Safety concerns (fall risk from hypokalemia-induced weakness, risk of aspiration from confusion due to hyponatremia) take precedence over comfort. Colloboration is essential. Work closely with physicians to interpret ABGs, adjust IV fluid rates based on clinical response, administer medications, and escalate concerns. In settings with limited laboratory access, clinical nursing assessment (vital signs, skin turgor, urine color and output, mental status, breath sounds) becomes the foundation of decision-making. Document fluid intake and output meticulously; this often-undervalued nursing function provides critical data for diagnosing and managing imbalances. Many patients, particularly those with chronic kidney disease, heart failure, or cirrhosis, are enrolled in the DOH's PhilPEN program or similar chronic disease management initiatives. Your patient teaching should align with program guidelines: sodium and fluid restriction in heart failure, potassium restriction in CKD, medication adherence, regular follow-up. For patients not yet formally enrolled, nurse-initiated screening and referral to appropriate programs can improve outcomes. In resource-limited settings, it is important to use available resources wisely. Blood gas analysis may not always be immediately available, but clinical assessment (respiratory rate and depth, mental status, vital signs) can guide initial management while awaiting lab results. IV fluids should be administered judiciously, with careful attention to I&O, because aggressive fluid administration in a patient without adequate urine output can cause iatrogenic FVE and pulmonary edema. **DISCHARGE PLANNING AND COMMUNITY FOLLOW-UP:** As patients prepare for discharge, ensure they understand their condition, medications, dietary restrictions, fluid recommendations, and warning signs. Provide written instructions in Filipino (if appropriate) that are easy to understand. Arrange follow-up with their primary care physician or specialist. For patients at high risk of readmission (those with heart failure, CKD, or multiple comorbidities), consider referral to community health workers or nurse visit programs if available. In the Philippine healthcare system, the role of the barangay health worker (BHW) is vital for community-level follow-up, particularly in rural areas.